Skip to main content
. 2023 Feb 22;13(3):417. doi: 10.3390/biom13030417

Table 1.

Summary of common posttranslational modification types, modification sites, regulatory factors, enrichment modes, and mass shifts in mass spectrometry.

PTM Modification Sites Regulatory Factors Enrichment Modes Mass Shif (Da)
phosphorylation serine, threonine, tyrosine protein kinase; protein phosphatase titanium dioxide 80
methylation lysine, arginine PKMTs, PRMTs lysine methylation antibody, arginine methylation antibody 14, 28, 42
oxidative modification methionine, tryptophan ROS oxPTMs antibody 4, 16, 32
ubiquitination lysine Ubiquitin activator E1, ubiquitin binding enzyme E2 and ubiquitin ligase E3 lysine ubiquitination antibody >1000, 114 after trypsinisation
acetylation lysine p300; SIRT1, SIRT3, SIRT6 lysine acetylated antibody 42
propionylation lysine p300, NATs (GCN5, PCAF), MYSTs (MOF, MOZ, HBO1); SIRT1-3 lysine propionylation antibody 56
butyrylation lysine p300, HBO1; SIRT1-3 lysine butyrylation antibody 70
malonylation lysine SIRT5 lysine malonylation antibody 86
glutarylation lysine p300, GNATs (GCN5); lysine glutarylation antibody 114
SIRT5, SIRT7
hydroxybutyrylation lysine p300 lysine hydroxybutyrylation antibody 86
2-hydroxyisobutyrylation lysine p300, MYSTs (ESa1p, Tip60); lysine 2-hydroxyisobutyrylation antibody 86
HDAC1-3, Rpd3p, CobB
succinylation lysine GNATs (GCN5, HAT1), CPT1A, KGDHC; SIRT5, SIRT7 lysine succinylation antibody 100
crotonylation lysine p300; HDAC-3, SIRT1-3 lysine crotonylation antibody 68
lactylation lysine p300; HDAC1-3, SIRT1-3 lysine lactylation antibody 72